Research Paper Volume 15, Issue 20 pp 11489—11507
Anti-cancer targets and molecular mechanisms of formononetin in treating osteosarcoma based on network pharmacology
Figure 8. (A) The electrostatic potential energy diagram of SATB2 and formononetin ligand. (B) The structural diagram showing the interaction between SATB2 and formononetin ligand. (C) The 2D structural diagram illustrating the interaction between ESR1 and formononetin ligand.